We have a range of patient derived cells available for use. These have been derived from patient samples and processed to optimise the growth in cell culture in an adherent manner. We have low passage number samples available and can have multiple samples at differing passages of the same sample.

These cells are available for use in our services or can be purchased under license from us for use in your own laboratory.

Assay Ready Reagents

If clients wish to carry out the PDC experiments in their own facility, we have the ready-to-assay vials available. These are part of our range of Assay Ready Reagents (ARR). The ARR range can be used directly for assays without the need to grow in-house by the customer.

More details of these options can be found here below and here. Furthermore, data associated with our biobank samples is also available for licensing for data applications, with additional details available here.

RNAseq data is available for some samples, or, as a service we offer can be derived on request as part of your service or in your own lab under our license. Additional characterisation is continually conducted by our scientists and added to the data sheets when available.

Over 500 samples are currently being stored and are available for expansion and use; cancer types and sub-types across a broad range of solid tumours, including primary and metastatic samples; carcinomas and sarcomas. Brief demographics of the patient are available for most samples.

Some popular cell types are broken down into further categorisation, but if your preferred cancer type is not listed, then contact our team, as not all samples are listed here.

If you feel that our BioBank does not cover your needs, please talk to our team about developing a bespoke model from freshly obtained biopsy samples.

Inaphaea’s PDC model approach is built on:

• Biobank of PDC models, 470 available, grown in-vitro directly from patient tumours.

• RNAseq data, for select cell lines.

• Stored at early passage numbers.

• PDC models available in both 2D and 3D options.

• Immuno-oncology assays (tumour infiltration models – cell killing).

• More representative of original tumour characteristics than cell lines.

Download and read more information on our PDC offerings & services by Inaphaea Biolabs which are available on this Inaphaea BioLabs Flyer.

Hear more about our PDC offering and frequently asked questions by watching the video below, featuring Inaphaea’s Scientific Advisor, Dr Gareth Griffiths.